Mono: Clinical trials have shown that silymarin (a Flavonoid) exerts hepatoprotective effects in acute viral hepatitis, poisoning by A phalloides, toxic hepatitis produced by psychotropic agents and alcohol-related liver disease by acting as a free radical scavenger. Has not been studies in Mono. Both work well together to protect the liver and can are being made in a combination product.
Answered 8/4/2014
3.8k views
4 doctors weighed in across 3 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question